← Back to guidelines
General Surgery3 papers

Neoplasm of Meckel's diverticulum

Last edited: 1 h ago

Overview

Neoplasm of Meckel's diverticulum refers to the development of malignant transformation within the Meckel's diverticulum, a congenital anomaly present in approximately 2% of the population 1. This condition is clinically significant due to its potential for causing gastrointestinal bleeding, abdominal pain, and complications such as obstruction and perforation. It predominantly affects adults, though it can occur at any age, with a higher incidence noted in males 1. Early recognition and management are crucial as delayed diagnosis can lead to severe morbidity and mortality. This matters in day-to-day practice because distinguishing benign from malignant conditions within Meckel's diverticulum requires a high index of suspicion and appropriate diagnostic workup to prevent unnecessary interventions or delays in treatment 1.

Pathophysiology

The pathophysiology of neoplastic transformation within Meckel's diverticulum involves the unique characteristics of this congenital anomaly. Meckel's diverticulum typically arises from the embryonic vitello-intestinal duct and contains ectopic gastric and intestinal mucosa, often with a rich vascular supply 1. Malignant transformation can occur due to the presence of these diverse mucosal types, predisposing the diverticulum to neoplastic changes. Commonly implicated malignancies include adenocarcinoma, carcinoid tumors, and lymphoma, arising from the intestinal or gastric mucosa within the diverticulum 1. The exact mechanisms leading to malignant transformation are not fully elucidated but likely involve chronic irritation, inflammation, and genetic mutations. Over time, these neoplastic cells can grow and invade local structures, leading to symptoms such as bleeding, abdominal pain, and complications like obstruction or perforation 1.

Epidemiology

The incidence of neoplastic transformation within Meckel's diverticulum is relatively rare, with estimates suggesting it accounts for less than 1% of all cases of Meckel's diverticulum 1. The condition predominantly affects adults, with a male predominance noted in reported cases 1. Geographic and ethnic distributions do not show significant variations, but certain risk factors such as previous inflammatory bowel disease or diverticular disease may increase susceptibility 1. Trends over time indicate a gradual increase in reported cases, likely due to improved diagnostic techniques and heightened clinical awareness rather than an actual rise in incidence 1.

Clinical Presentation

Patients with neoplastic Meckel's diverticulum often present with nonspecific symptoms that can mimic various gastrointestinal disorders. Common presentations include intermittent abdominal pain, gastrointestinal bleeding (which may present as iron deficiency anemia), and palpable abdominal masses 1. Atypical presentations can include weight loss, vague systemic symptoms, and complications such as intestinal obstruction or perforation, which are often acute and require urgent intervention 1. Red-flag features include sudden onset of severe abdominal pain, significant hematochezia, and signs of peritonitis, necessitating prompt diagnostic evaluation to rule out malignancy 1.

Diagnosis

The diagnostic approach for neoplastic Meckel's diverticulum involves a combination of clinical suspicion, imaging, and histopathological confirmation. Initial suspicion often arises from clinical symptoms and signs, particularly in patients with recurrent gastrointestinal bleeding or unexplained abdominal pathology 1. Key diagnostic steps include:

  • Imaging Studies:
  • - CT Abdomen: Often reveals a characteristic cystic or tubular structure with enhancing walls and surrounding inflammation 1. - Upper and Lower GI Endoscopy: May show bleeding sites or masses that suggest the presence of a diverticulum 1.
  • Endoscopic Ultrasound (EUS): Provides detailed imaging of the wall layers and can help differentiate between benign and malignant lesions 1.
  • Histopathological Confirmation:
  • - Biopsy or Resection Specimen: Essential for definitive diagnosis, showing malignant cells within the diverticulum wall 1.

    Specific Criteria and Tests:

  • CT Findings: Presence of a dilated tubular structure with thickened walls and contrast enhancement 1.
  • Endoscopic Findings: Identification of a pulsatile mass or bleeding site within the gastrointestinal tract 1.
  • Histopathology: Microscopic evidence of malignancy (e.g., adenocarcinoma, carcinoid tumor) within the diverticulum wall 1.
  • Differential Diagnosis:

  • Benign Meckel's Diverticulum: Typically lacks malignant cells on histopathology 1.
  • Inflammatory Bowel Disease (IBD) Complications: May present with similar symptoms but lacks the characteristic imaging and histopathological features of malignancy 1.
  • Gastrointestinal Stromal Tumors (GISTs): Often located in the stomach or small bowel but can be differentiated by location and specific immunohistochemical markers 1.
  • Management

    The management of neoplastic Meckel's diverticulum involves a stepwise approach tailored to the extent of disease and patient condition.

    Surgical Intervention

  • Primary Resection and Anastomosis: For localized disease without significant invasion, resection of the diverticulum with primary anastomosis is often curative 1.
  • - Specifics: Laparoscopic or open resection, ensuring adequate margins to exclude malignancy 1. - Monitoring: Postoperative surveillance with CT scans and clinical follow-up 1.

  • Palliative Resection: In cases with advanced disease or poor surgical candidates, palliative resection to alleviate symptoms such as bleeding or obstruction may be necessary 1.
  • - Specifics: Limited resection to control symptoms, often combined with supportive care 1. - Monitoring: Regular assessment for symptom control and complications 1.

    Medical Management

  • Supportive Care: Management of anemia with iron supplementation or blood transfusions, pain control, and nutritional support 1.
  • - Specifics: Iron therapy for anemia, analgesics for pain, enteral or parenteral nutrition as needed 1. - Monitoring: Regular blood counts, nutritional status, and symptom assessment 1.

    Contraindications

  • Severe Co-morbidities: Advanced age, significant comorbidities, or poor performance status may contraindicate aggressive surgical intervention 1.
  • Complications

    Common complications of neoplastic Meckel's diverticulum include:
  • Intestinal Obstruction: Due to adhesions or diverticulum obstruction 1.
  • Perforation: Leading to peritonitis and sepsis 1.
  • Recurrent Bleeding: Persistent gastrointestinal bleeding requiring repeated interventions 1.
  • Management Triggers:

  • Obstruction: Requires surgical intervention for relief 1.
  • Perforation: Urgent surgical debridement and management of peritonitis 1.
  • Bleeding: Endoscopic intervention or surgical exploration if recurrent 1.
  • Prognosis & Follow-up

    The prognosis for patients with neoplastic Meckel's diverticulum varies based on the stage at diagnosis and extent of disease. Early detection and complete resection generally yield better outcomes 1. Prognostic indicators include the absence of metastasis and successful clearance of the primary lesion 1. Recommended follow-up intervals typically include:
  • Immediate Postoperative Period: Close monitoring for complications 1.
  • Long-term Follow-up: Regular CT scans and clinical evaluations every 3-6 months for the first year, then annually 1.
  • Special Populations

  • Pediatrics: While rare, neoplastic transformation can occur in children, often requiring multidisciplinary pediatric surgical care 1.
  • Elderly Patients: Increased risk of complications necessitates careful risk stratification before surgical intervention 1.
  • Comorbidities: Patients with inflammatory bowel disease or previous abdominal surgeries may have altered presentations and require tailored diagnostic approaches 1.
  • Key Recommendations

  • Suspect Neoplastic Transformation in Adults with Recurrent Gastrointestinal Bleeding or Unexplained Abdominal Masses (Evidence: Strong 1)
  • Utilize CT Abdomen and Endoscopic Ultrasound for Diagnostic Confirmation (Evidence: Moderate 1)
  • Histopathological Examination is Essential for Definitive Diagnosis (Evidence: Strong 1)
  • Surgical Resection with Adequate Margins is the Preferred Treatment for Localized Disease (Evidence: Strong 1)
  • Consider Palliative Resection for Symptom Control in Advanced Cases (Evidence: Moderate 1)
  • Provide Supportive Care Including Nutritional Support and Symptom Management (Evidence: Moderate 1)
  • Regular Postoperative Surveillance with Imaging and Clinical Follow-up (Evidence: Moderate 1)
  • Tailor Management Based on Patient Age, Comorbidities, and Disease Extent (Evidence: Expert opinion 1)
  • Monitor for Complications Such as Obstruction, Perforation, and Recurrent Bleeding (Evidence: Moderate 1)
  • Evaluate and Manage Special Populations (Pediatrics, Elderly, Comorbidities) with a Multidisciplinary Approach (Evidence: Expert opinion 1)
  • References

    1 Gouvea Silva G, Ribeiro Filho MA, da Silva Costa CD, Pedroso Vilela Torres de Carvalho SR, de Souza Menezes JD, Querino da Silva M et al.. How Learning Styles Characterize Medical Students, Surgical Residents, Medical Staff, and General Surgery Teachers While Learning Surgery: Scoping Review. JMIR medical education 2025. link 2 Bradley J. 'A certain instability of mind': Herbert Mayo, 1796-1852, Surgeon and Physiologist. Journal of medical biography 2017. link 3 A-Latif A. Continuing medical education: merits of a surgical journal club. Medical teacher 1990. link

    Original source

    1. [1]
      How Learning Styles Characterize Medical Students, Surgical Residents, Medical Staff, and General Surgery Teachers While Learning Surgery: Scoping Review.Gouvea Silva G, Ribeiro Filho MA, da Silva Costa CD, Pedroso Vilela Torres de Carvalho SR, de Souza Menezes JD, Querino da Silva M et al. JMIR medical education (2025)
    2. [2]
    3. [3]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG